Latest Videos
Video
Dr. Matthew Summers, Program Director of Structural Heart and Co-Director of the Sentara Heart Valve Center at Sentara, discusses the need for pre-procedural planning using computational modeling to guide treatment options for cardiac ...
Video
ESMO25 Breast Cancer Highlights
Harold Burstein, MD, PhD, and other breast cancer experts at Dana-Farber discuss important breast cancer research presented at ESMO 2025.
Video
2025 ESMO Prostate Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ESMO 2025
Video
2025 ESMO Kidney Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2025.
Video
2025 ESMO Bladder Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from ESMO 2025.
Video
Group 2 PH: The Overlooked Link Between Heart and Lung Health
Dr. Raymond Benza shares key insights from his ongoing work and discusses the evolving landscape of treatment for Group 2 pulmonary hypertension.
Video
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients
While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.
Video
FLAURA2 Lung Cancer Study Presented by Pasi Jänne, MD, PhD
Dana-Farber Cancer Institute's Dr. Pasi Jänne details FLAURA2 which found first-line osimertinib + platinum pemetrexed chemotherapy improved overall survival vs. monotherapy in EGFR mutated non-small cell lung cancer, including poorer prognosis patients.
Latest Documents
Document
The Breast Oncology Center at Dana-Farber Brigham Cancer Center held meetings to discuss recommendations regarding the use of inavolisib, palbociclib, and fulvestrant in patients with hormone receptor-positive/HER2-negative metastatic breast cancer.
Latest Articles
News
Dana-Farber researchers to present findings at 2025 San Antonio Breast Cancer Symposium
Physician scientists from Dana-Farber Cancer Institute will present more than 50 research studies at the 48th annual San Antonio Breast Cancer Symposium, December 9-12.
News
Musculoskeletal Interventions in Oncology: Creating New Options
Interventional radiology (IR) has emerged as a transformative force in musculoskeletal oncology, significantly impacting the clinical management of bone and soft tissue tumors.
News
Why Patients Who Need a Lung Transplant Are Often Referred Too Late
A lung transplant expert explains why many doctors wait too long to get their patients onto a transplant waiting list.
News
Baptist Health Neurosurgeon's Innovation: A New Helmet to Make Surfing Safer
In the world of high-intensity sports, the risk of head injury is a constant concern. While sports like football and hockey have long benefited from advanced protective gear — others, like surfing, have lagged behind.
Latest Courses
Course
Myelopathy Through a Surgeon's Lens
In this CME, Kathryn S. Hoes, MD, discusses how to identify anatomic correlates of clinical relevance, define myelopathy accurately, conduct a relevant patient history, interpret key physical examination findings, and recognize key radiographic ...
Course
Updates in Cardiac Transplant, VAD, and Cardiogenic Shock
In this CME, Amanda Ann Hopwood, PA-C, discusses how to explain the role of bloodless medicine in VAD and Transplant, implement improved documentation of cardiogenic shock cases, and analyze patient access through education on transplant ...
Course
In this CME, Stalin Dharmayan, MD, discusses how to explain the need for vascular access, describe the options for vascular access, and implement post-op case for vascular.
Course
The Tip of the Iceberg: A Thorough Workup of Autonomic Dysreflexia
In this CME, Caroline M. Vail, DO, discusses how clinicians can quickly identify typical and atypical symptoms of autonomic dysreflexia (AD) to better prevent it, thus hopefully mitigating cardiovascular comorbidities for patients with ...
